License AgreementLicense Agreement • February 12th, 2025 • PMGC Holdings Inc. • Pharmaceutical preparations • Delaware
This License Agreement (“Agreement”), dated as of April 30, 2024 (the “Effective Date”), is by and between MOA Life Plus Co., Ltd., a corporation duly organized and existing under Korean law, with its head office at A-7F U-Tower, 767, Sinsu-ro, Suji-gu, Yongin-si, Gyeonggi-do, 16827, Korea, hereby represented by Sangjin Han, Chairman (hereinafter referred to as “MOA”), and Elevai Labs Inc., a corporation existing under the laws of Delaware, with its headquarters located at 120 Newport Center Drive, Suite 250, Newport Beach, California 92660, U.S.A., hereby represented by Jordan Plews (hereinafter referred to as “Elevai”) (collectively, the “Parties,” or each, individually, a “Party”).
License AgreementLicense Agreement • May 2nd, 2024 • Elevai Labs Inc. • Pharmaceutical preparations • Delaware
This License Agreement (“Agreement”), dated as of April 30, 2024 (the “Effective Date”), is by and between MOA Life Plus Co., Ltd., a corporation duly organized and existing under Korean law, with its head office at A-7F U-Tower, 767, Sinsu-ro, Suji-gu, Yongin-si, Gyeonggi-do, 16827, Korea, hereby represented by Sangjin Han, Chairman (hereinafter referred to as “MOA”), and Elevai Labs Inc., a corporation existing under the laws of Delaware, with its headquarters located at 120 Newport Center Drive, Suite 250, Newport Beach, California 92660, U.S.A., hereby represented by Jordan Plews (hereinafter referred to as “Elevai”) (collectively, the “Parties,” or each, individually, a “Party”).